@wsj.com on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

The Wall Street Journal

wsj.com

did:plc:i3fhjvvkbmirhyu4aeihhrnv

Shares fell sharply after the Danish drugmaker said its CagriSema experimental obesity drug failed to beat the weight loss delivered by Eli Lilly’s Zepbound in a head-to-head clinical trial. on.wsj.com/4kPxbV3 https://on.wsj.com/4kPxbV3

2026-02-23T10:14:32.752Z